Point72 Asset Management L.P. 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:48 pm Sale |
2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA |
Point72 Asset Management L.P. | 0 0.000% |
-3,030,283 (Position Closed) |
Filing |
| 2024-02-14 4:18 pm Purchase |
2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Point72 Asset Management L.P. | 3,030,283 5.800% |
30,283 (+1.01%) |
Filing |
| 2023-11-16 5:00 pm Purchase |
2023-11-15 | 13G | Lyra Therapeutics, Inc. LYRA |
Point72 Asset Management L.P. | 3,000,000 5.400% |
3,000,000 (New Position) |
Filing |